醒脑静治疗脑梗死急性期的临床效果初步研究

A preliminary study on the clinical effect of Xingnaojing Injection in treating acute cerebral infarction

目的探讨脑静治疗脑梗死急性期的临床效果。方法选择32例脑梗死急性期患者作为研究对象,随机分为对照组和观察组,各16例。两组均常规救治,在此基础上对照组采用吡拉西坦治疗,观察组采用醒脑静治疗,观察两组患者治疗后神经功能缺损、炎性因子等改善效果。结果治疗后:观察组临床神经功能缺损治疗总有效率(93.75%)显著高于对照组(62.50%);观察组血清TNF-α[(1.36±0.45)ng/L]和IL-6[(56.25±19.56)ng/L]水平均显著低于对照组[(1.96±0.39)ng/L、(76.24±21.32)ng/L];差异均有统计学意义(P﹤0.05)。结论醒脑静治疗脑梗死急性期的临床效果可靠。

Objective To investigate the clinical effect of cerebral infarction in the acute stage of cerebral infarction. Methods 32 patients with acute cerebral infarction were randomly divided into the control group and the observation group, 16 cases in each group. The two groups were treated with conventional treatment, on the basis of the control group by the Laci Staw treatment, observation group were treated with Xingnaojing treatment, neurologic impairment, inflammatory factor and improvement effect was observed after treatment in two groups. Results After treatment,the observation group clinical neurological defect treatment efficiency (93.75%) was significantly higher than the control group (62.50%); the observation group and the control group of serum TNF- [(1.36 ± 0.45) ng/L] and IL-6[(56.25 ± 19.56) ng/L] levels were significantly lower than the control group [(1.96 ± 0.39) ng/L, (76.24 ± 21.32) ng/L]; the differences between groups were significant differences were statistically significant (P ﹤0.05). Conclusion The clinical effect of Xingnaojing Injection in the treatment of acute cerebral infarction is reliable.